| |
||||
 |
 |
|||
|
|
What is DILIN?To promote research on the causes of drug-induced liver disease, the National Institute of Diabetes and Digestive and Kidney Diseases has created the Drug-Induced Liver Injury Network(DILIN) . Its purpose is to collect and carefully analyze cases of liver problems caused by prescription drugs and alternative medicines, such as herbal products. Two studies are being conducted by DILIN. In the "Retrospective Study," the goal is to establish a registry of people who experienced a liver injury due to taking any of 4 specific drugs (isoniazid [INH], phenytoin [Dilantin], clavulanic acid/amoxicillin [Augmentin], and valproic acid [Depakote] within the past 10 years. In the "Prospective Study," patients who recently (within the last 6 months) experienced an adverse liver reaction after taking any drug or alternative product will be studied. |
|||